T. Rowe Price Investment Management, Inc. Exact Sciences Corp Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 2,919,029 shares of EXAS stock, worth $120 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
2,919,029
Previous 4,269,823
31.64%
Holding current value
$120 Million
Previous $240 Million
47.33%
% of portfolio
0.08%
Previous 0.15%
Shares
11 transactions
Others Institutions Holding EXAS
# of Institutions
638Shares Held
160MCall Options Held
1.64MPut Options Held
1.5M-
Capital World Investors Los Angeles, CA17.8MShares$731 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$723 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$512 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$495 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$271 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.25B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...